Stocks

MeiraGTx Holdings PLC

MGTXNASDAQUSDHealthcare

About MeiraGTx Holdings PLC

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase ½ clinical trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.

Ticker
MGTX
Trading on
NASDAQ
ISIN
KYG596651029
Industry
Biotechnology
Sector
Healthcare
CEO
Dr. Alexandria Forbes Ph.D.
Headquarters
655 Third Avenue, New York, NY, United States, 10017
Employees
393
Website
meiragtx.com

Metrics

Market cap$1.36B
P/E ratio16.31
EPS$0.87
Dividend Yield0.00%
Beta1.26
Forward P/E ratio64.1
EBIDTA$196M
Ex dividend date-

Analyst Insights & forecasts

Buy100%
Hold0%
Sell0%

Based on information from 5 analysts.

Average price target$29.43

Earnings per share (EPS) forecast

Q3 • 25Q4 • 25Q1 • 26
Actual-$0.62$0.19-$0.57
Expected-$0.49-$0.56-$0.45
Surprise-26.53%133.69%-26.67%
MissedBeatCurrent

Financial Performance

Q1 • 26Q2 • 26QoQ growth
Revenue$0.3M$321M109,604.44%
Net income$-46.3M$161M-447.03%
Profit margin-15,806.48%50.00%-100.32%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

FAQs

01How much is a MeiraGTx Holdings PLC share?

MeiraGTx Holdings PLC shares are currently traded for undefined per share.

02How many shares does MeiraGTx Holdings PLC have?

MeiraGTx Holdings PLC currently has 96M shares.

03Does MeiraGTx Holdings PLC pay dividends?

No, MeiraGTx Holdings PLC doesn't pay dividends.

04What is MeiraGTx Holdings PLC 52 week high?

MeiraGTx Holdings PLC 52 week high is $15.35.

05What is MeiraGTx Holdings PLC 52 week low?

MeiraGTx Holdings PLC 52 week low is $6.62.

06What is the 200-day moving average of MeiraGTx Holdings PLC?

MeiraGTx Holdings PLC 200-day moving average is $9.63.

07Who is MeiraGTx Holdings PLC CEO?

The CEO of MeiraGTx Holdings PLC is Dr. Alexandria Forbes Ph.D..

08How many employees MeiraGTx Holdings PLC has?

MeiraGTx Holdings PLC has 393 employees.

09What is the market cap of MeiraGTx Holdings PLC?

The market cap of MeiraGTx Holdings PLC is $1.36B.

10What is the P/E of MeiraGTx Holdings PLC?

The current P/E of MeiraGTx Holdings PLC is 16.31.

11What is the EPS of MeiraGTx Holdings PLC?

The EPS of MeiraGTx Holdings PLC is $0.87.

12What is the PEG Ratio of MeiraGTx Holdings PLC?

The PEG Ratio of MeiraGTx Holdings PLC is null.

13What do analysts say about MeiraGTx Holdings PLC?

According to the analysts MeiraGTx Holdings PLC is considered a buy.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.